Our Research Publications
Updated August 2024
Pagination
- Previous page
- Page 20
- Next page
Title | Authors | Year Sort ascending | Journal | Link to Article | Intended Audience | Purpose |
---|---|---|---|---|---|---|
Development and evaluation of a generic population pharmacokinetic model for standard half-life factor VIII for use in dose individualization | McEneny-King A, Chelle P, Foster G, Keepanasseril A, Iorio A, Edginton AN | 2019 | J Pharmacokinet Pharmacodyn | View Development and evaluation of a generic population pharmacokinetic model for standard half-life factor VIII for use in dose individualization | Researchers | Clinical research |
Sex-mismatched red blood cell transfusions and mortality: A systematic review and meta-analysis | Zeller MP, Rochwerg B, Jamula E, Li N, Hillis C, Acker JP, Runciman RJR, Lane SJ, Ahmed N, Arnold DM, Heddle NM | 2019 | Vox Sang | View Sex-mismatched red blood cell transfusions and mortality: A systematic review and meta-analysis | Researchers | Clinical research |
What is the role of rapid molecular testing for seniors and other at-risk adults with respiratory syncytial virus infections? | Drews SJ, Branche AR, Falsey AR, Lee N | 2019 | J Clin Virol | View What is the role of rapid molecular testing for seniors and other at-risk adults with respiratory syncytial virus infections? | Health care providers | Clinical research |
Concentré de recherche : Un sur un million : un modèle pour gérer les réserves de sang rare | Blake J, Clarke G | 2019 | Blood.ca website | View Concentré de recherche : Un sur un million : un modèle pour gérer les réserves de sang rare | Researchers | Clinical research |
A platelet viability assay (PVA) for the diagnosis of heparin-induced thrombocytopenia | Ivetic N, Arnold D, Smith J, Huynh A, Kelton J, Nazy I | 2019 | Platelets | View A platelet viability assay (PVA) for the diagnosis of heparin-induced thrombocytopenia | Researchers | Basic research |
Fetal and neonatal alloimmune thrombocytopenia: recommendations for evidence-based practice, an international approach | Lieberman L, Greinacher A, Murphy M, Bussel J, Bakchoul T, Corke S, Killie M, Kjeldsen-Kragh J, Bertrand G, Oepkes D, Baker J, Hume H, Massey E, Kaplan C, Arnold D, Baidya S, Ryan G, Savoia H, Landry D, Shehata N | 2019 | Br J Haematol | View Fetal and neonatal alloimmune thrombocytopenia: recommendations for evidence-based practice, an international approach | Health care providers | Benchmarking and standard setting |
Circulaire d'information utilisation de composants sanguins humains: Composants plasmatiques | Jenkins C | 2019 | Blood.ca website | View Circulaire d'information utilisation de composants sanguins humains: Composants plasmatiques | Health care providers | Benchmarking and standard setting |
Establishing the Prevalence and Prevalence at Birth of Hemophilia in Males: A Meta-analytic Approach Using National Registries | Iorio A, Stonebraker JS, Chambost H, Makris M, Coffin D, Herr C, Germini F, for the Data Demographics Committee of the World Federation of Hemophilia | 2019 | Ann Intern Med | View Establishing the Prevalence and Prevalence at Birth of Hemophilia in Males: A Meta-analytic Approach Using National Registries | Researchers | Clinical research |
Ischemic limb necrosis in septic shock: What is the role of high-dose vasopressor therapy? | Levy JH, Ghadimi K, Faraoni D, van Diepen S, Levy B, Hotchkiss R, Connors JM, Iba T, Warkentin TE | 2019 | J Thromb Haemost | View Ischemic limb necrosis in septic shock: What is the role of high-dose vasopressor therapy? | Researchers | Clinical research |
Système Kell : l’anticorps anti-Kpa | Peng S, Meunier D | 2019 | Blood.ca website | View Système Kell : l’anticorps anti-Kpa | Health care providers | Benchmarking and standard setting |
Trends in IVIG use at a tertiary care Canadian center and impact of provincial use mitigation strategies: 10-year retrospective study with interrupted time series analysis | Murphy MSQ, Tinmouth A, Goldman M, Chasse M, Colas JA, Saidenberg E, Shehata N, Fergusson D, Forster AJ, Wilson K | 2019 | Transfusion | View Trends in IVIG use at a tertiary care Canadian center and impact of provincial use mitigation strategies: 10-year retrospective study with interrupted time series analysis | Researchers | Clinical research |
Syndrome respiratoire aigu post-transfusionnel (TRALI) | Petraszko T | 2019 | Blood.ca website | View Syndrome respiratoire aigu post-transfusionnel (TRALI) | Researchers | Clinical research |
Glycoprotein V is a relevant immune target in patients with immune thrombocytopenia | Vollenberg R, Jouni R, Norris PAA, Burg-Roderfeld M, Cooper N, Rummel MJ, Bein G, Marini I, Bayat B, Burack R, Lazarus AH, Bakchoul T, Sachs UJ | 2019 | Haematologica | View Glycoprotein V is a relevant immune target in patients with immune thrombocytopenia | Researchers | Basic research |
MNS System: Anti-M | Clarke G, Côté J, Lane D | 2019 | Blood.ca website | View MNS System: Anti-M | Health care providers | Benchmarking and standard setting |
ResearchUnit: Fighting inflammation with inflammation | Lazarus A | 2019 | Blood.ca website | View ResearchUnit: Fighting inflammation with inflammation | Researchers | Clinical research |
Treating murine inflammatory diseases with an anti-erythrocyte antibody | Crow AR, Kapur R, Koernig S, Campbell IK, Jen C-C, Mott PJ, Marjoram D, Khan R, Kim M, Brasseit J, Cruz-Leal Y, Amash A, Kahlon S, Yougbare I, Ni H, Zuercher AW, Käsermann F, Semple JW, Lazarus AH | 2019 | Sci Transl Med | View Treating murine inflammatory diseases with an anti-erythrocyte antibody | Researchers | Basic research |
Thrombopénie néonatale par allo-immunisation fÅ“tomaternelle: Brochure d'information | International Collaboration for Transfusion Medicine Guidelines | 2019 | ICTMG.org website | View Thrombopénie néonatale par allo-immunisation fÅ“tomaternelle: Brochure d'information | Other | Other |
ResearchUnit: Modeling risk to ensure safety when considering changes to blood testing | O'Brien S | 2019 | Blood.ca website | View ResearchUnit: Modeling risk to ensure safety when considering changes to blood testing | Researchers | Basic research |
Variations in RBC and frozen plasma utilization rates across 62 Ontario community hospitals | Qiang JK, Thompson T, Callum J, Pinkerton P, Lin Y | 2019 | Transfusion | View Variations in RBC and frozen plasma utilization rates across 62 Ontario community hospitals | Health care providers | Clinical research |
The association between platelet transfusions and mortality in patients with critical illness | Ning S, Liu Y, Barty R, Cook R, Rochwerg B, Iorio A, Warkentin TE, Heddle NM, Arnold DM | 2019 | Transfusion | View The association between platelet transfusions and mortality in patients with critical illness | Researchers | Clinical research |
Diego System: Anti-Dia | Meunier D, Peng S, Clarke G | 2019 | Blood.ca website | View Diego System: Anti-Dia | Health care providers | Benchmarking and standard setting |
The impact of red blood cell manufacturing variables on bacterial growth dynamics: a pilot study | Ramirez-Arcos S, Kou Y, Cayer M-P, De Grandmont M-J, Girard M, Cloutier M | 2019 | Vox Sang | View The impact of red blood cell manufacturing variables on bacterial growth dynamics: a pilot study | Researchers | Basic research |
Overcoming the deceptively low viability of CD45+ cells in thawed cord blood unit segments | Pasha R, Halpenny M, Pineault N | 2019 | Vox Sang | View Overcoming the deceptively low viability of CD45+ cells in thawed cord blood unit segments | Researchers | New or improved product or process |
How we treat paroxysmal nocturnal hemoglobinuria: A consensus statement of the Canadian PNH Network and review of the national registry | Patriquin CJ, Kiss T, Caplan S, Chin-Yee I, Grewal K, Grossman J, Larratt L, Marceau D, Nevill T, Sutherland DR, Wells RA, Leber B | 2019 | Eur J Haematol | View How we treat paroxysmal nocturnal hemoglobinuria: A consensus statement of the Canadian PNH Network and review of the national registry | Researchers | Clinical research |
Assessing the Threat: Public Concern | Wiles A, Bennett JL, Devine D | 2019 | Blood Safety : A Guide to Monitoring and Responding to Potential New Threats | View Assessing the Threat: Public Concern | Other | Benchmarking and standard setting |
Evaluating the Clinical Effect of Female Blood Donors of Child-Bearing Age on Maternal and Neonatal Outcomes: A Cohort Study | Chassé M, Tinmouth A, Goldman M, O'Brien SF, Hawken S, Murphy MSQ, Walker M, Sprague AE, Wilson K, van Walraven C, Fergusson DA | 2019 | Transfus Med Rev | View Evaluating the Clinical Effect of Female Blood Donors of Child-Bearing Age on Maternal and Neonatal Outcomes: A Cohort Study | Researchers | Clinical research |
Postnatal intervention for the treatment of FNAIT: a systematic review | Baker JM, Shehata N, Bussel J, Murphy MF, Greinacher A, Bakchoul T, Massey E, Lieberman L, Landry D, Tanael S, Arnold DM, Baidya S, Bertrand G, Kjaer M, Kaplan C, Kjeldsen-Kragh J, Oepkes D, Savoia H, Ryan G, Hume H, On behalf of the International Collaboration for Transfusion Medicine Guidelines (ICTMG) | 2019 | J Perinatol | View Postnatal intervention for the treatment of FNAIT: a systematic review | Health care providers | Clinical research |
Système Lewis : les anticorps anti-Lewis | Peng S, Meunier D | 2019 | Blood.ca website | View Système Lewis : les anticorps anti-Lewis | Health care providers | Benchmarking and standard setting |
Changes in minimum hemoglobin and interdonation interval: impact on donor hemoglobin and donation frequency | Goldman M, Yi Q-L, Steed T, O'Brien SF | 2019 | Transfusion | View Changes in minimum hemoglobin and interdonation interval: impact on donor hemoglobin and donation frequency | Researchers | New or improved product or process |
Transfusion-related acute lung injury (TRALI) | Petraszko T | 2019 | Blood.ca website | View Transfusion-related acute lung injury (TRALI) | Researchers | Clinical research |
Virus envelope tissue factor promotes infection in mice | Sutherland MR, Simon AY, Shanina I, Horwitz MS, Ruf W, Pryzdial ELG | 2019 | J Thromb Haemost | View Virus envelope tissue factor promotes infection in mice | Researchers | Basic research |
Safeguarding the Patient's Own Blood Supply | Zeller MP, Kaufman RM | 2019 | JAMA | View Safeguarding the Patient's Own Blood Supply | Health care providers | Clinical research |
Concentré de recherche: Transfusion de culots globulaires?: lien entre la non-concordance des sexes et la mortalité | Zeller M | 2019 | Blood.ca website | View Concentré de recherche: Transfusion de culots globulaires?: lien entre la non-concordance des sexes et la mortalité | Health care providers | Clinical research |
Model Human ? Thalassemic Erythrocytes: Effect of Unpaired Purified ?-Hemoglobin Chains on Normal Erythrocytes | Scott M | 2019 | Beta Thalassemia | View Model Human ? Thalassemic Erythrocytes: Effect of Unpaired Purified ?-Hemoglobin Chains on Normal Erythrocytes | Researchers | Basic research |
Trombocitopenia alloimmune fetale e neonatale: Informazioni per il paziente | International Collaboration for Transfusion Medicine Guidelines | 2019 | ICTMG.org website | View Trombocitopenia alloimmune fetale e neonatale: Informazioni per il paziente | Other | Other |
Concentré de recherche : Dépistage d'agents pathogènes : la modélisation du risque au service de la sécurité de l'approvisionnement en sang | O'Brien S | 2019 | Blood.ca website | View Concentré de recherche : Dépistage d'agents pathogènes : la modélisation du risque au service de la sécurité de l'approvisionnement en sang | Researchers | Basic research |
Cross-linked hemoglobin bis-tetramers from bioorthogonal coupling do not induce vasoconstriction in the circulation | Wang A, Singh S, Yu B, Bloch DB, Zapol WM, Kluger R | 2019 | Transfusion | View Cross-linked hemoglobin bis-tetramers from bioorthogonal coupling do not induce vasoconstriction in the circulation | Researchers | Basic research |
Bacterial survival in whole blood depends on plasma sensitivity and resistance to neutrophil killing | Taha M, Kyluik-Price D, Kumaran D, Scott MD, Toyofuku W, Ramirez-Arcos S | 2019 | Transfusion | View Bacterial survival in whole blood depends on plasma sensitivity and resistance to neutrophil killing | Researchers | Basic research |
Diego System: Anti-Wra | Meunier D, Peng S, Clarke G | 2019 | Blood.ca website | View Diego System: Anti-Wra | Health care providers | Benchmarking and standard setting |
Perioperative Management of Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant | Douketis JD, Spyropoulos AC, Duncan J, Carrier M, Le Gal G, Tafur AJ, Vanassche T, Verhamme P, Shivakumar S, Gross PL, Lee AYY, Yeo E, Solymoss S, Kassis J, Le Templier G, Kowalski S, Blostein M, Shah V, MacKay E, Wu C, Clark NP, Bates SM, Spencer FA, Arnaoutoglou E, Coppens M, Arnold DM, Caprini JA, Li N, Moffat KA, Syed S, Schulman S | 2019 | JAMA Intern Med | View Perioperative Management of Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant | Health care providers | Benchmarking and standard setting |
The peptidoglycan and biofilm matrix of Staphylococcus epidermidis undergo structural changes when exposed to human platelets | Loza-Correa M, Ayala JA, Perelman I, Hubbard K, Kalab M, Yi Q-L, Taha M, de Pedro MA, Ramirez-Arcos S | 2019 | PLoS One | View The peptidoglycan and biofilm matrix of Staphylococcus epidermidis undergo structural changes when exposed to human platelets | Researchers | Basic research |
Circular of information for the use of human blood components: Plasma Components | Jenkins C | 2019 | Blood.ca website | View Circular of information for the use of human blood components: Plasma Components | Health care providers | Benchmarking and standard setting |
Kell System: Anti-Jsa | Meunier D, Peng S, Clarke G | 2019 | Blood.ca website | View Kell System: Anti-Jsa | Health care providers | Benchmarking and standard setting |
Pour un bon équilibre : protection des données dan les travaux de recherche | Ward R | 2019 | Blood.ca website | View Pour un bon équilibre : protection des données dan les travaux de recherche | Health care providers | Other |
Système Lutheran : l’anticorps anti-Lua | Meunier D, Peng S, Clarke G | 2019 | Blood.ca website | View Système Lutheran : l’anticorps anti-Lua | Health care providers | Benchmarking and standard setting |
Biocompatibility and toxicity of novel iron chelator Starch-Deferoxamine (S-DFO) compared to zinc oxide nanoparticles to zebrafish embryo: An oxidative stress based apoptosis, physicochemical and neurological study profile | Nasrallah GK, Salem R, Da'as S, Al-Jamal OLA, Scott M, Mustafa I | 2019 | Neurotoxicol Teratol | View Biocompatibility and toxicity of novel iron chelator Starch-Deferoxamine (S-DFO) compared to zinc oxide nanoparticles to zebrafish embryo: An oxidative stress based apoptosis, physicochemical and neurological study profile | Researchers | Basic research |
The AABB Donor History Questionnaire | O'Brien S, Carayiannis S | 2019 | Screening Blood Donors with the Donor History Questionnaire | View The AABB Donor History Questionnaire | Blood operators | Benchmarking and standard setting |
Correction to: Routine clinical care data for population pharmacokinetic modeling: the case for Fanhdi/Alphanate in hemophilia A patients | Chelle P, Yeung CHT, Bonanad S, Morales Munoz JC, Ozelo MC, Megias Vericat JE, Iorio A, Spears J, Mir R, Edginton A | 2019 | J Pharmacokinet Pharmacodyn | View Correction to: Routine clinical care data for population pharmacokinetic modeling: the case for Fanhdi/Alphanate in hemophilia A patients | Health care providers | Clinical research |
Guidelines on the intraoperative transfusion of red blood cells: a protocol for systematic review | Baker L, Park L, Gilbert R, Martel A, Ahn H, Davies A, McIsaac DI, Saidenberg E, Tinmouth A, Fergusson DA, Martel G | 2019 | BMJ Open | View Guidelines on the intraoperative transfusion of red blood cells: a protocol for systematic review | Health care providers | Clinical research |
Modelling the Need for New Blood Donors Following a Change in Deferral Period | Blake J | 2019 | Industrial Engineering and Operations Management | View Modelling the Need for New Blood Donors Following a Change in Deferral Period | Researchers | New or improved product or process |